Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107502

Glucose Turnover and Disposal in Maturity-Onset Diabetes

H. F. Bowen and J. A. Moorhouse

Endocrine and Metabolism Laboratory, Winnipeg General Hospital, Winnipeg, Manitoba, Canada, R3E 0Z3

Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada, R3E 0Z3

Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada, R3E 0Z3

Find articles by Bowen, H. in: PubMed | Google Scholar

Endocrine and Metabolism Laboratory, Winnipeg General Hospital, Winnipeg, Manitoba, Canada, R3E 0Z3

Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada, R3E 0Z3

Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada, R3E 0Z3

Find articles by Moorhouse, J. in: PubMed | Google Scholar

Published December 1, 1973 - More info

Published in Volume 52, Issue 12 on December 1, 1973
J Clin Invest. 1973;52(12):3033–3045. https://doi.org/10.1172/JCI107502.
© 1973 The American Society for Clinical Investigation
Published December 1, 1973 - Version history
View PDF
Abstract

The glucose turnover rate in maturity-onset diabetes in man has been variously reported as increased, normal, and decreased. The present experiments suggest that these discrepancies may have been due to methodology, and to nonrecognition of a circadian cycle in the glucose turnover rate that is present in health, and marked in diabetes.

During the early morning hours the glucose turnover rate in maturity-onset diabetes is increased in proportion to the fasting blood glucose level. It may reach three to four times the rate found in health. During the evening hours the increments are about one-half as great.

The glucose outflow rate constant, k, lower in diabetes than in health, is also lower in both groups in the evening than in the morning.

An analysis of the relative contributions of glucose overproduction and underutilization to the development of hyperglycemia in maturity-onset diabetes indicates that overproduction is the greater factor. The relative role of underutilization appears to increase as the fasting blood glucose level increases.

The circulating glucose oxidation rate in maturity-onset diabetes is only slightly lower than in health, but the fraction oxidized is markedly lower, and only a small fraction is excreted.

The principal conclusion is that in maturity-onset diabetes there is a hypertrophied flux of endogenous glucose, most of which is neither oxidized nor excreted. The precursors and the qualitative and quantitative metabolic fates of this excess glucose are unknown.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 3033
page 3033
icon of scanned page 3034
page 3034
icon of scanned page 3035
page 3035
icon of scanned page 3036
page 3036
icon of scanned page 3037
page 3037
icon of scanned page 3038
page 3038
icon of scanned page 3039
page 3039
icon of scanned page 3040
page 3040
icon of scanned page 3041
page 3041
icon of scanned page 3042
page 3042
icon of scanned page 3043
page 3043
icon of scanned page 3044
page 3044
icon of scanned page 3045
page 3045
Version history
  • Version 1 (December 1, 1973): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts